Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Sensors (Basel, Switzerland)|December 5, 2012
Development of a novel, fully-automated genotyping system: principle and applicationsShun-Ichi Suzuki, Mariko Komori, Mitsuharu Hirai, et al.
Pathology International|September 4, 2020
Peritoneal adenomatoid (microcystic) mesotheliomaDaisuke Mori, Shinichi Kido, Masatsugu Hiraki, et al.
Oncology Research|April 9, 2011
A fully integrated and automated detection system for single nucleotide polymorphisms of UGT1A1 and CYP2C19Norio Ureshino, Naoko Aragane, Tomomi Nakamura, et al.
Medical Oncology (Northwood, London, England)|November 11, 2017
Severity and predictive factors of adverse events in pemetrexed-containing chemotherapy for non-small cell lung cancerTsuyoshi Miyahara, Naoko Sueoka-Aragane, Kentaro Iwanaga, et al.
Oncology Reports|June 14, 2011
A fully integrated, automated and rapid detection system for KRAS mutationsNorio Ureshino, Naoko Sueoka-Aragane, Tomomi Nakamura, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 17, 2011
A noninvasive system for monitoring resistance to epidermal growth factor receptor tyrosine kinase inhibitors with plasma DNATomomi Nakamura, Naoko Sueoka-Aragane, Kentaro Iwanaga, et al.
Pathology Oncology Research : POR|January 7, 2017
Detection of KRAS Mutations in Plasma DNA Using a fully Automated Rapid Detection System in Colorectal Cancer PatientsKazuhisa Hosoya, Satoshi Matsusaka, Tomomi Kashiwada, et al.
BMC Cancer|January 4, 2022
Prognostic nomogram for patients with unresectable pancreatic cancer treated with gemcitabine plus nab-paclitaxel or FOLFIRINOX: A post-hoc analysis of a multicenter retrospective study in Japan (NAPOLEON study)Taro Shibuki, Toshihiko Mizuta, Mototsugu Shimokawa, et al.
International Journal of Clinical Oncology|May 20, 2023
Scoring model with serum albumin and CA19-9 for metastatic pancreatic cancer in second-line treatment: results from the NAPOLEON studyAzusa Komori, Satoshi Otsu, Mototsugu Shimokawa, et al.
Cancer Chemotherapy and Pharmacology|August 1, 2020
A phase I/II study of S-1 and irinotecan (IRIS) combined with cetuximab in patients with RAS wild-type metastatic colorectal cancer (KSCC1401)Hironori Samura, Eiji Oki, Hiroshi Okumura, et al.
Pageof 2